{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T14:27:13Z","timestamp":1789050433680,"version":"build-2803163510"},"reference-count":63,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,10]],"date-time":"2024-04-10T00:00:00Z","timestamp":1712707200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000780","name":"European Union","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007048","name":"EEA Grants and Norway Grants","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007048","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014434","name":"NAWA","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014434","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004569","name":"Ministry of Education and Science of the Republic of Poland","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004569","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020098","name":"Innovative Medicines Initiative","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020098","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004281","name":"National Science Centre Poland","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004281","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.ijbiomac.2024.131392","type":"journal-article","created":{"date-parts":[[2024,4,4]],"date-time":"2024-04-04T16:15:55Z","timestamp":1712247355000},"page":"131392","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"P1","title":["SARS-CoV-2 Mpro oligomerization as a potential target for therapy"],"prefix":"10.1016","volume":"267","author":[{"given":"Kinga","family":"Lis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacek","family":"Plewka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filipe","family":"Menezes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewa","family":"Bielecka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuliya","family":"Chykunova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarzyna","family":"Pustelny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Niebling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelica Struve","family":"Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Garcia-Alai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grzegorz M.","family":"Popowicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Czarna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomasz","family":"Kantyka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krzysztof","family":"Pyrc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijbiomac.2024.131392_bb0005","series-title":"WHO Coronavirus (COVID-19)","year":"2023"},{"key":"10.1016\/j.ijbiomac.2024.131392_bb0010","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1021\/acscombsci.0c00058","article-title":"Targeting the dimerization of the Main protease of coronaviruses: a potential broad-Spectrum therapeutic strategy","volume":"22","author":"Goyal","year":"2020","journal-title":"ACS Comb. Sci."},{"key":"10.1016\/j.ijbiomac.2024.131392_bb0015","article-title":"The SARS-CoV-2 main protease (M pro): structure, function, and emerging therapies for COVID-19","volume":"3","author":"Hu","year":"2022","journal-title":"MedComm (Beijing)"},{"key":"10.1016\/j.ijbiomac.2024.131392_bb0020","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/s41586-020-2223-y","article-title":"Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors","volume":"582","author":"Jin","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.ijbiomac.2024.131392_bb0025","article-title":"The SARS-CoV-2 main protease (M pro): structure, function, and emerging therapies for COVID-19","volume":"3","author":"Hu","year":"2022","journal-title":"MedComm (Beijing)"},{"key":"10.1016\/j.ijbiomac.2024.131392_bb0030","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.virol.2009.03.034","article-title":"Two adjacent mutations on the dimer interface of SARS coronavirus 3C-like protease cause different conformational changes in crystal structure","volume":"388","author":"Hu","year":"2009","journal-title":"Virology"},{"key":"10.1016\/j.ijbiomac.2024.131392_bb0035","doi-asserted-by":"crossref","first-page":"5047","DOI":"10.1038\/s41467-020-18709-w","article-title":"Crystallographic and electrophilic fragment screening of the SARS-CoV-2 main protease","volume":"11","author":"Douangamath","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ijbiomac.2024.131392_bb0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmb.2021.167118","article-title":"A crystallographic snapshot of SARS-CoV-2 Main protease maturation process","volume":"433","author":"Noske","year":"2021","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.ijbiomac.2024.131392_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2022.101972","article-title":"Structural basis for the in vitro efficacy of nirmatrelvir against SARS-CoV-2 variants","volume":"298","author":"Greasley","year":"2022","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijbiomac.2024.131392_bb0050","doi-asserted-by":"crossref","first-page":"5196","DOI":"10.1038\/s41467-022-32854-4","article-title":"X-ray crystallographic characterization of the SARS-CoV-2 main protease polyprotein cleavage sites essential for viral processing and maturation","volume":"13","author":"Lee","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ijbiomac.2024.131392_bb0055","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1107\/S0907444913001315","article-title":"Mechanism for controlling the monomer\u2013dimer conversion of SARS coronavirus main protease","volume":"69","author":"Wu","year":"2013","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"10.1016\/j.ijbiomac.2024.131392_bb0060","doi-asserted-by":"crossref","first-page":"3213","DOI":"10.1093\/emboj\/cdf327","article-title":"Structure of coronavirus main proteinase reveals combination of a chymotrypsin fold with an extra alpha-helical domain","volume":"21","author":"Anand","year":"2002","journal-title":"EMBO J."},{"key":"10.1016\/j.ijbiomac.2024.131392_bb0065","doi-asserted-by":"crossref","first-page":"24765","DOI":"10.1074\/jbc.M311744200","article-title":"Dissection study on the severe acute respiratory syndrome 3C-like protease reveals the critical role of the extra domain in dimerization of the enzyme","volume":"279","author":"Shi","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijbiomac.2024.131392_bb0070","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1038\/s42003-022-03910-y","article-title":"Autoprocessing and oxyanion loop reorganization upon GC373 and nirmatrelvir binding of monomeric SARS-CoV-2 main protease catalytic domain","volume":"5","author":"Nashed","year":"2022","journal-title":"Commun Biol"},{"key":"10.1016\/j.ijbiomac.2024.131392_bb0075","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1111\/j.1742-4658.2006.05130.x","article-title":"The catalysis of the SARS 3C-like protease is under extensive regulation by its extra domain","volume":"273","author":"Shi","year":"2006","journal-title":"FEBS J."},{"key":"10.1016\/j.ijbiomac.2024.131392_bb0080","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/s42003-022-03084-7","article-title":"Modulation of the monomer-dimer equilibrium and catalytic activity of SARS-CoV-2 main protease by a transition-state analog inhibitor","volume":"5","author":"Nashed","year":"2022","journal-title":"Commun Biol"},{"key":"10.1016\/j.ijbiomac.2024.131392_bb0085","doi-asserted-by":"crossref","first-page":"607","DOI":"10.3390\/biom11040607","article-title":"SARS-CoV-2 Mpro: a potential target for Peptidomimetics and small-molecule inhibitors","volume":"11","author":"Citarella","year":"2021","journal-title":"Biomolecules"},{"key":"10.1016\/j.ijbiomac.2024.131392_bb0090","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.3390\/biom13091339","article-title":"Recent advances in SARS-CoV-2 Main protease inhibitors: from Nirmatrelvir to future perspectives","volume":"13","author":"Citarella","year":"2023","journal-title":"Biomolecules"},{"issue":"2021","key":"10.1016\/j.ijbiomac.2024.131392_bb0095","first-page":"1586","article-title":"An oral SARS-CoV-2 M pro inhibitor clinical candidate for the treatment of COVID-19","volume":"374","author":"Owen","year":"1979","journal-title":"Science"},{"key":"10.1016\/j.ijbiomac.2024.131392_bb0100","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1021\/acscentsci.3c00538","article-title":"Naturally occurring mutations of SARS-CoV-2 Main protease confer drug resistance to Nirmatrelvir","volume":"9","author":"Hu","year":"2023","journal-title":"ACS Cent. Sci."},{"key":"10.1016\/j.ijbiomac.2024.131392_bb0105","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.ade8778","article-title":"Transmissible SARS-CoV-2 variants with resistance to clinical protease inhibitors","volume":"9","author":"Moghadasi","year":"2023","journal-title":"Sci. Adv."},{"key":"10.1016\/j.ijbiomac.2024.131392_bb0110","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1007\/s00044-022-02951-6","article-title":"The history, mechanism, and perspectives of nirmatrelvir (PF-07321332): an orally bioavailable main protease inhibitor used in combination with ritonavir to reduce COVID-19-related hospitalizations","volume":"31","author":"Joyce","year":"2022","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.ijbiomac.2024.131392_bb0115","doi-asserted-by":"crossref","DOI":"10.1128\/mbio.00869-22","article-title":"Genetic surveillance of SARS-CoV-2 M pro reveals high sequence and structural conservation prior to the introduction of protease inhibitor Paxlovid","volume":"13","author":"Lee","year":"2022","journal-title":"MBio"},{"key":"10.1016\/j.ijbiomac.2024.131392_bb0120","first-page":"3336","article-title":"Maturation of the SARS-CoV-2 virus is regulated by dimerization of its main protease, Comput Struct","volume":"20","author":"Kaptan","year":"2022","journal-title":"Biotechnol. J."},{"key":"10.1016\/j.ijbiomac.2024.131392_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2023.104559","article-title":"To, global prevalence of SARS-CoV-2 3CL protease mutations associated with nirmatrelvir or ensitrelvir resistance","volume":"91","author":"Ip","year":"2023","journal-title":"EBioMedicine"},{"key":"10.1016\/j.ijbiomac.2024.131392_bb0130","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1038\/s41422-022-00640-y","article-title":"The P132H mutation in the main protease of omicron SARS-CoV-2 decreases thermal stability without compromising catalysis or small-molecule drug inhibition","volume":"32","author":"Sacco","year":"2022","journal-title":"Cell Res."},{"key":"10.1016\/j.ijbiomac.2024.131392_bb0135","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2022.882288","article-title":"Biophysical screening pipeline for Cryo-EM grid preparation of membrane proteins","volume":"9","author":"Niebling","year":"2022","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.ijbiomac.2024.131392_bb0140","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1107\/S2059798321008998","article-title":"Garcia Alai, eSPC: an online data-analysis platform for molecular biophysics","volume":"77","author":"Burastero","year":"2021","journal-title":"Acta Crystallogr D Struct Biol"},{"key":"10.1016\/j.ijbiomac.2024.131392_bb0145","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1107\/S0907444909047337","article-title":"XDS","volume":"66","author":"Kabsch","year":"2010","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"10.1016\/j.ijbiomac.2024.131392_bb0150","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1107\/S0021889807021206","article-title":"Phaser crystallographic software","volume":"40","author":"McCoy","year":"2007","journal-title":"J. Appl. Cryst."},{"key":"10.1016\/j.ijbiomac.2024.131392_bb0155","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1107\/S0907444910007493","article-title":"Features and development of coot","volume":"66","author":"Emsley","year":"2010","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"10.1016\/j.ijbiomac.2024.131392_bb0160","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1107\/S2052252514009324","article-title":"The PDB_REDO server for macromolecular structure model optimization","volume":"1","author":"Joosten","year":"2014","journal-title":"IUCrJ"},{"key":"10.1016\/j.ijbiomac.2024.131392_bb0165","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1002\/jcc.20084","article-title":"UCSF chimera\u2014a visualization system for exploratory research and analysis","volume":"25","author":"Pettersen","year":"2004","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.ijbiomac.2024.131392_bb0170","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.softx.2015.06.001","article-title":"GROMACS: high performance molecular simulations through multi-level parallelism from laptops to supercomputers","volume":"1\u20132","author":"Abraham","year":"2015","journal-title":"SoftwareX"},{"key":"10.1016\/j.ijbiomac.2024.131392_bb0175","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1002\/jcc.23354","article-title":"CHARMM36 all-atom additive protein force field: validation based on comparison to NMR data","volume":"34","author":"Huang","year":"2013","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.ijbiomac.2024.131392_bb0180","doi-asserted-by":"crossref","first-page":"3586","DOI":"10.1021\/jp973084f","article-title":"All-atom empirical potential for molecular modeling and dynamics studies of proteins","volume":"102","author":"MacKerell","year":"1998","journal-title":"J. Phys. Chem. B"},{"key":"10.1016\/j.ijbiomac.2024.131392_bb0185","doi-asserted-by":"crossref","DOI":"10.33011\/livecoms.1.1.5068","article-title":"From proteins to perturbed Hamiltonians: a suite of tutorials for the GROMACS-2018 molecular simulation package [article v1.0]","volume":"1","author":"Lemkul","year":"2019","journal-title":"Living J Comput Mol Sci"},{"key":"10.1016\/j.ijbiomac.2024.131392_bb0190","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1002\/prot.20784","article-title":"Generalized correlation for biomolecular dynamics, proteins: structure","volume":"62","author":"Lange","year":"2006","journal-title":"Function, and Bioinformatics"},{"key":"10.1016\/j.ijbiomac.2024.131392_bb0195","doi-asserted-by":"crossref","first-page":"3685","DOI":"10.1021\/acs.jcim.2c00757","article-title":"ULYSSES\u00a0: an efficient and easy to use Semiempirical library for C++","volume":"62","author":"Menezes","year":"2022","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.ijbiomac.2024.131392_bb0200","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1021\/acs.jctc.8b01176","article-title":"GFN2-xTB\u2014an accurate and broadly parametrized self-consistent tight-binding quantum chemical method with multipole electrostatics and density-dependent dispersion contributions","volume":"15","author":"Bannwarth","year":"2019","journal-title":"J. Chem. Theory Comput."},{"key":"10.1016\/j.ijbiomac.2024.131392_bb0205","doi-asserted-by":"crossref","first-page":"4250","DOI":"10.1021\/acs.jctc.1c00471","article-title":"Robust and efficient implicit solvation model for fast Semiempirical methods","volume":"17","author":"Ehlert","year":"2021","journal-title":"J Chem Theory Comput"},{"key":"10.1016\/j.ijbiomac.2024.131392_bb0210","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1002\/pro.3943","article-title":"<scp>UCSF ChimeraX<\/scp>\u00a0: structure visualization for researchers, educators, and developers","volume":"30","author":"Pettersen","year":"2021","journal-title":"Protein Sci."},{"key":"10.1016\/j.ijbiomac.2024.131392_bb0215","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1002\/pro.3235","article-title":"Meeting modern challenges in visualization and analysis","volume":"27","author":"Goddard","year":"2018","journal-title":"Protein Sci."},{"key":"10.1016\/j.ijbiomac.2024.131392_bb0220","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s00249-021-01513-9","article-title":"Standard protocol for mass photometry experiments","volume":"50","author":"Wu","year":"2021","journal-title":"Eur. Biophys. J."},{"key":"10.1016\/j.ijbiomac.2024.131392_bb0225","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/s41392-023-01392-w","article-title":"A new generation Mpro inhibitor with potent activity against SARS-CoV-2 omicron variants","volume":"8","author":"Huang","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.ijbiomac.2024.131392_bb0230","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1038\/s41564-022-01119-7","article-title":"An orally available Mpro inhibitor is effective against wild-type SARS-CoV-2 and variants including omicron","volume":"7","author":"Quan","year":"2022","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.ijbiomac.2024.131392_bb0235","doi-asserted-by":"crossref","first-page":"5815","DOI":"10.1021\/acs.jcim.0c00575","article-title":"SARS-CoV-2 Main protease: a molecular dynamics study","volume":"60","author":"Su\u00e1rez","year":"2020","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.ijbiomac.2024.131392_bb0240","first-page":"282","article-title":"Activation and maturation of SARS-CoV main protease, protein","volume":"2","author":"Xia","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.ijbiomac.2024.131392_bb0245","doi-asserted-by":"crossref","first-page":"4227","DOI":"10.1128\/JVI.02612-07","article-title":"Without its N-finger, the Main protease of severe acute respiratory syndrome coronavirus can form a novel dimer through its C-terminal domain","volume":"82","author":"Zhong","year":"2008","journal-title":"J. Virol."},{"key":"10.1016\/j.ijbiomac.2024.131392_bb0250","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.bbrc.2005.11.102","article-title":"The N-terminal octapeptide acts as a dimerization inhibitor of SARS coronavirus 3C-like proteinase","volume":"339","author":"Wei","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ijbiomac.2024.131392_bb0255","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2022.102023","article-title":"Key dimer interface residues impact the catalytic activity of 3CLpro, the main protease of SARS-CoV-2","volume":"298","author":"Ferreira","year":"2022","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijbiomac.2024.131392_bb0260","doi-asserted-by":"crossref","first-page":"14958","DOI":"10.1021\/bi0490237","article-title":"Quaternary structure of the severe acute respiratory syndrome (SARS) coronavirus Main protease","volume":"43","author":"Chou","year":"2004","journal-title":"Biochemistry"},{"key":"10.1016\/j.ijbiomac.2024.131392_bb0265","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1038\/s41467-023-37035-5","article-title":"An in-solution snapshot of SARS-COV-2 main protease maturation process and inhibition","volume":"14","author":"Noske","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ijbiomac.2024.131392_bb0270","doi-asserted-by":"crossref","first-page":"3745","DOI":"10.3390\/molecules25163745","article-title":"Putative SARS-CoV-2 Mpro inhibitors from an in-house library of natural and nature-inspired products: a virtual screening and molecular docking study","volume":"25","author":"Mazzini","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.ijbiomac.2024.131392_bb0275","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1099\/0022-1317-81-4-853","article-title":"Virus-encoded proteinases and proteolytic processing in the Nidovirales","volume":"81","author":"Gorbalenya","year":"2000","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.ijbiomac.2024.131392_bb0280","doi-asserted-by":"crossref","first-page":"22741","DOI":"10.1074\/jbc.M502556200","article-title":"Critical assessment of important regions in the subunit association and catalytic action of the severe acute respiratory syndrome coronavirus Main protease","volume":"280","author":"Hsu","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijbiomac.2024.131392_bb0285","doi-asserted-by":"crossref","first-page":"4620","DOI":"10.1128\/JVI.02680-07","article-title":"Mechanism for controlling the dimer-monomer switch and coupling dimerization to catalysis of the severe acute respiratory syndrome coronavirus 3C-like protease","volume":"82","author":"Shi","year":"2008","journal-title":"J. Virol."},{"key":"10.1016\/j.ijbiomac.2024.131392_bb0290","doi-asserted-by":"crossref","first-page":"14908","DOI":"10.1021\/bi0616302","article-title":"Long-range cooperative interactions modulate dimerization in SARS 3CL pro","volume":"45","author":"Barrila","year":"2006","journal-title":"Biochemistry"},{"key":"10.1016\/j.ijbiomac.2024.131392_bb0295","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.abb.2008.01.023","article-title":"Correlation between dissociation and catalysis of SARS-CoV main protease","volume":"472","author":"Lin","year":"2008","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.ijbiomac.2024.131392_bb0300","doi-asserted-by":"crossref","first-page":"2463","DOI":"10.2147\/DDDT.S370574","article-title":"Allosteric binding sites of the SARS-CoV-2 Main protease: potential targets for broad-Spectrum anti-coronavirus agents","volume":"16","author":"Alzyoud","year":"2022","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.ijbiomac.2024.131392_bb0305","doi-asserted-by":"crossref","first-page":"23544","DOI":"10.1002\/anie.202010316","article-title":"Allosteric inhibition of the SARS-CoV-2 Main protease: insights from mass spectrometry based assays**","volume":"59","author":"El-Baba","year":"2020","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.ijbiomac.2024.131392_bb0310","doi-asserted-by":"crossref","first-page":"4308","DOI":"10.1021\/bi1002585","article-title":"Mutation of Asn28 disrupts the dimerization and enzymatic activity of SARS 3CL pro","volume":"49","author":"Barrila","year":"2010","journal-title":"Biochemistry"},{"key":"10.1016\/j.ijbiomac.2024.131392_bb0315","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0144865","article-title":"Critical assessment of the important residues involved in the dimerization and catalysis of MERS coronavirus Main protease","volume":"10","author":"Ho","year":"2015","journal-title":"PloS One"}],"updated-by":[{"DOI":"10.1016\/j.ijbiomac.2024.133473","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000}}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813024021974?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813024021974?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T21:05:47Z","timestamp":1728421547000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813024021974"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":63,"alternative-id":["S0141813024021974"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2024.131392","relation":{"erratum":[{"id-type":"doi","id":"10.1016\/j.ijbiomac.2024.133473","asserted-by":"object"}]},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"SARS-CoV-2 Mpro oligomerization as a potential target for therapy","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2024.131392","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"131392"}}